Cell Counting Market size is set to growth with a CAGR of 7.31% till 2026
The recent Cell Counting Market outlook for 2020- 2026 by OG Analysis identifies growing incidences of target diseases and blood disorders, development of enhanced solutions and improved image analysis as the impacting factors shaping the market growth.
Further, cell counting market is largely driven by the growing use of high-throughput flow cytometry and automated haematology analyzers with benefits of improved research and diagnostics applications as well as efficient analysis of blood samples.
Moreover, the increasing prevalence of health issues such as cancer, blood-related disorders, infectious diseases, and HIV/AIDS along with availability of enhanced reagents serves to support cell counting market growth.
However, inadequate infrastructure for research in emerging countries and absence of skilled professionals in clinical laboratories are amid major challenges of cell counting market.
Adoption of POC Testing is boosting cell counting market
The growing competition among the major OEMs developing POCT equipment for cell counting and the rise in adoption of POC diagnostic tests by hospitals, clinics due to cost containment largely drives the market growth.
With recent advancements, portable POC equipment to measure haemoglobin content with high performance are increasingly trending the market. Recently, DiaSpect Medical developed DiaSpect Tm to measure haemoglobin content in the body, a palm-sized analyzer that provides laboratory quality performance to screen for anemia. On similar lines, HomeCue, offers POCT for common blood tests which is portable and gives WBC results in minutes.
Key players are untapping market opportunity over innovative cell counting products
The cell counting market segment showcases strong growth over expansion of product portfolio of both products and consumables. Key companies are keenly focussing on automated haematology analyzers with scalability, high-performance levels, and decrease the hands-on time of operating personnel features. Accordingly, in 2018, Danaher Corporation launched the DxH 900 hematology analyzer, giving clinical laboratories the ability to perform complete blood count and white blood cell differential tests with minimal repeats.
Ongoing technological developments with a collaborative approach to improve overall performance of flow cytometry instruments and assay workflow with morphological analysis is increasingly adopted by major players. Accordingly, in April 2018, BioTek Instruments collaborated with Agilent Technologies to create a new integrated metabolic analysis and imaging platform to improve assay workflow.
Further, research in the field of immunological disorders, drug discovery, stem cells, and in vitro cytotoxicity testing supports the demand for cell counting instruments and consumables.
Key players of cell counting market are Danaher Corporation, Thermo Fisher Scientific, Becton, Dickinson and Company, Merck, GEHealthcare, Agilent Technologies, BioTek Instruments, Abbott Laboratories, and SiemensHealthineers.
Product development, low-cost pricing and alternative shape the market dynamics
The intense competition in the cell counting market is largely based on the cost of manufacturing and the design of the product; key manufacturers are trying to top the cell counting market by developing and commercializing cost-effective products in the market.
Asia Pacific proceeds with strong cell counting market growth
The cell counting market across Asia Pacific is emerging with significant growth in the research industry. China and India are entering as potential market holders for cell counting instruments.
Owing to increasing expenditure by private and public organizations on research and development, and improving healthcare infrastructure supplements the market growth across the region.
The high unmet medical needs and the rising demand for cutting-edge technologies are attracting global leaders in the market to invest across Asia Pacific.
Further, progress across North America shows significant cell counting market growth. A majority of this market growth is driven by the significant progress across research industry with focus on biomedical, stem cells, and cancer research.